Patent ID: 11919858
Assignee: CALGENT BIOTECHNOLOGY CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 2:
3. The method of claim 1, wherein m is 0; R1 is halogen; n is any integer of 1-2; R3 is H; X is C(O); R4 is H; and R5 is OH, C3-8cycloalkyl, pyridinyl, phenyl substituted by one to three of NH2, halogen, OH, CN or C1-4alkylpiperazinyl; pyrimidinyl unsubstituted or substituted with NO2, NH2 or C1-4alkyl; pyrazinyl unsubstituted or substituted with NO2, NH2 or C1-4alkyl; thiazolyl unsubstituted or substituted with NO2, NH2 or C1-4alkyl; benzimidazolyl unsubstituted or substituted with NO2, NH2 or C1-4alkyl; pyrazolyl unsubstituted or substituted with NO2, NH2 or C1-4alkyl; indazolyl unsubstituted or substituted with NO2, NH2 or C1-4alkyl; quinolinyl unsubstituted or substituted with NO2, NH2 or C1-4alkyl; indolyl unsubstituted or substituted with NO2, NH2 or C1-4alkyl; azaindazolyl unsubstituted or substituted with NO2, NH2 or C1-4alkyl; deazapurinyl unsubstituted or substituted with NO2, NH2 or C1-4alkyl; indanyl unsubstituted or substituted with NO2, NH2 or C1-4alkyl; or morpholinoyl unsubstituted or substituted with NO2, NH2 or C1-4alkyl; or a tautomer, enantiomer, stereoisomer thereof, or a solvate or a pharmaceutically acceptable salt thereof.